These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Research suppressed for seven years by drug company. Wise J BMJ; 1997 Apr; 314(7088):1145. PubMed ID: 9146378 [No Abstract] [Full Text] [Related]
6. Bioequivalence of levothyroxine preparations: industry sponsorship and academic freedom. Eckert CH JAMA; 1997 Apr; 277(15):1200-1. PubMed ID: 9103338 [No Abstract] [Full Text] [Related]
7. Implications of pharmaceutical industry funding on clinical research. Lexchin JR Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137 [TBL] [Abstract][Full Text] [Related]
8. Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising. DeGroot LJ JAMA; 1997 Sep; 278(11):895; author reply 898-9. PubMed ID: 9302231 [No Abstract] [Full Text] [Related]
9. A duty to publish. Nat Med; 1998 Oct; 4(10):1089. PubMed ID: 9771720 [No Abstract] [Full Text] [Related]
11. Sponsors lose fight to stop thyroxine study publication. McCarthy M Lancet; 1997 Apr; 349(9059):1149. PubMed ID: 11654726 [No Abstract] [Full Text] [Related]
12. Balancing communication and safety. Ehrlich SA Science; 2006 Dec; 314(5804):1387. PubMed ID: 17138880 [No Abstract] [Full Text] [Related]
13. The case against blanket First Amendment protection of scientific research: articulating a more limited scope of protection. Keane S Stanford Law Rev; 2006 Oct; 59(2):505-50. PubMed ID: 17153275 [No Abstract] [Full Text] [Related]
14. Company tried to bar report that H.I.V. vaccine failed. Hilts PJ N Y Times Web; 2000 Nov; ():A24. PubMed ID: 12159838 [No Abstract] [Full Text] [Related]
15. Industry sponsorship in research and publishing: who is really to blame for perceived bias? Amsden GW Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974 [No Abstract] [Full Text] [Related]
16. Publishing sensitive data: who calls the shots? Journals joust over conflict-of-interest rules. Marshall E Science; 1997 Apr; 276(5312):524. PubMed ID: 9148406 [No Abstract] [Full Text] [Related]
17. The negotiation and development of a clinical trial agreement. Finn PB J Biolaw Bus; 2006; 9(2):21-7. PubMed ID: 17111523 [TBL] [Abstract][Full Text] [Related]
18. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry. Dorfman HL; Reig LP Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876 [No Abstract] [Full Text] [Related]
19. How to doctor the media. Nelkin D New Sci; 1986 Nov; 112(1535):51-6. PubMed ID: 11655814 [No Abstract] [Full Text] [Related]
20. Why I oppose drug company payment of physician/investigators on a per patient/subject basis. Roizen R IRB; 1988; 10(1):9-10. PubMed ID: 11658990 [No Abstract] [Full Text] [Related] [Next] [New Search]